Drug manufacturer Eli Lilly for the fifth time this year has announced refunds for overcharges on 340B-acquired drugs. The latest round is for purchases during the first quarter of 2020.
The U.S. Health Resources and Services Administration posted Lilly’s notice yesterday. Lilly said
Drug manufacturer Eli Lilly for the fifth time this year has announced refunds for overcharges on 340B-acquired drugs.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.